Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 01-2002 | 10-2001 | 07-2001 | 04-2001 | 01-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68 | -31 | -34 | -677 | -446 |
| Depreciation Amortization | 36 | 24 | 12 | 56 | 36 |
| Income taxes - deferred | N/A | N/A | N/A | 208 | N/A |
| Accounts receivable | 1 | 1 | 1 | 113 | 111 |
| Accounts payable and accrued liabilities | -66 | -24 | -5 | 78 | 70 |
| Other Working Capital | -142 | -81 | 10 | 266 | 242 |
| Other Operating Activity | 65 | 23 | 3 | 100 | 89 |
| Operating Cash Flow | $-174 | $-88 | $-12 | $145 | $102 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -1 | N/A | -34 | -34 |
| Net Acquisitions | N/A | N/A | N/A | -242 | N/A |
| Other Investing Activity | 20 | 0 | 0 | 0 | -220 |
| Investing Cash Flow | $13 | $-1 | $N/A | $-276 | $-254 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8 | -5 | -2 | -8 | -6 |
| Financing Cash Flow | $-8 | $-5 | $-2 | $-8 | $-6 |
| Beginning Cash Position | 452 | 452 | 452 | 591 | 591 |
| End Cash Position | 283 | 359 | 438 | 452 | 434 |
| Net Cash Flow | $-169 | $-93 | $-14 | $-140 | $-158 |
| Free Cash Flow | |||||
| Operating Cash Flow | -174 | -88 | -12 | 145 | 102 |
| Capital Expenditure | -7 | -1 | N/A | -34 | -34 |
| Free Cash Flow | -181 | -88 | -12 | 111 | 69 |